How Well Does A New Alzheimer's Drug Work For...

If you’ve ever seen a crime show, you probably know how the plot unfolds: A victim is found, an investigation ensues and police conduct a high-stakes search for the culprit. Detectives and crime lab techs collect hair, examine bullet casings and photograph bloodstains. But just h ...  Show more

It’s been just over two years since the rise of Make America Healthy Again, or MAHA. The movement united a coalition of moms, wellness influencers and voters across the political spectrum over concerns about chronic illness and childhood diseases. And when Robert F. Kennedy Jr. t ...  Show more

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  Show more

A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ...  Show more